Owner and operator of biotechnology firm intended to eradicate infectious diseases using a novel, patented technology platform. The company's platform addresses the growing antibiotic resistance problems and creating a revolutionary treatment paradigm for viral diseases like Tamiflu alternative for influenza, emerging infectious diseases and biodefense, enabling doctors to provide effective treatment for influenza, creating a powerful alternative to Tamiflu and rabies.